Assenagon Asset Management »

4d Molecular Therapeutics In shares owned by Assenagon Asset Management

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Assenagon Asset Management from 13F filings

Historical chart of Assenagon Asset Management investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Assenagon Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Assenagon Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $14M 431k 31.86